Zn(II)-Curcumin Complexes-Based Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Materials Science
• Oncology

Background:

• Platinum(II)-derivatives are widely used in cancer treatment but face challenges like poor solubility and bioavailability.
• Bioactive ligands are being explored to enhance the efficacy and targeting of metallodrugs.
• Curcumin, a natural compound, has demonstrated significant biological activities, including anticancer properties.

Purpose of the Study:

• To synthesize and characterize zinc(II)-curcumin coordination complexes for cancer therapy.
• To investigate the impact of functional groups, targeting ligands, and photo-active ligands on anticancer potential.
• To review the current status and future prospects of curcumin-based metallodrugs.

Main Methods:

• Synthesis of various zinc(II)-curcumin coordination complexes.
• Structural elucidation of the synthesized complexes.
• In vitro evaluation of anticancer properties and mechanism of action.

Main Results:

• Successful synthesis of diverse Zn(II)-curcumin complexes with varying functionalization.
• Demonstrated enhancement in anticancer activity and cancer cell targeting upon ligand modification.
• Evidence of improved bioavailability and reduced toxicity compared to traditional agents.

Conclusions:

• Zinc(II)-curcumin complexes represent a promising class of metallodrugs for cancer treatment.
• Strategic modification of ligands can significantly optimize their therapeutic efficacy.
• Further research into these complexes holds potential for developing next-generation anticancer therapies.